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Cholinergic signaling is fundamental to neuromuscular function in most organisms. Sub-
lethal doses of neurotoxic pesticides that target cholinergic signaling can alter the behavior
of insects in subtle ways; their influence on non-target organisms may not be readily
apparent in simple mortality studies. Beneficial arthropods such as honeybees perform
sophisticated behavioral sequences during foraging that, if influenced by pesticides, could
impair foraging success and reduce colony health. Here, we investigate the behavioral
effects on honeybees of exposure to a selection of pesticides that target cholinergic sig-
naling by inhibiting acetylcholinesterase (AChE). To examine how continued exposure to
AChE inhibitors affected motor function, we fed adult foraging worker honeybees sub-
lethal concentrations of these compounds in sucrose solution for 24 h. Using an assay for
locomotion in bees, we scored walking, stopped, grooming, and upside down behavior
continuously for 15 min. At a 10 nM concentration, all the AChE inhibitors caused similar
effects on behavior, notably increased grooming activity and changes in the frequency of
bouts of behavior such as head grooming. Coumaphos caused dose-dependent effects
on locomotion as well as grooming behavior, and a 1µM concentration of coumaphos
induced symptoms of malaise such as abdomen grooming and defecation. Biochemical
assays confirmed that the four compounds we assayed (coumaphos, aldicarb, chlorpyri-
fos, and donepezil) or their metabolites acted as AChE inhibitors in bees. Furthermore, we
show that transcript expression levels of two honeybee AChE inhibitors were selectively
upregulated in the brain and in gut tissues in response to AChE inhibitor exposure. The
results of our study imply that the effects of pesticides that rely on this mode of action
have subtle yet profound effects on physiological effects on behavior that could lead to
reduced survival.
Keywords: honeybee, honey bee, acetylcholinesterase inhibitor, acetylcholine, pesticide, motor function,
coumaphos, aldicarb
INTRODUCTION
Populations of honeybees and other pollinating insects have pre-
cipitously declined in many countries worldwide in the past
20 years. The spread of parasites and pathogens in domesti-
cated honeybee populations has reduced the survival of managed
colonies and eliminated wild colonies from some countries alto-
gether. Exposure to new forms of pesticide that target insect
acetylcholine receptors (AChRs) is also emerging as a major con-
tributing factor in bee population decline (Le Conte et al., 2010;
Maxim and van der Sluijs, 2010).
The decline in bee populations may represent an inability on
the part of bees to adapt to multiple forms of stress from par-
asites, pathogens, and pesticides. In particular, major changes in
the nature of the bee’s within-hive chemical environment have
occurred as a result of the use of chemicals meant to target the par-
asitic mite,Varroa destructor (Rosenkranz et al., 2010). Acaricides
accumulate inside the hive, with lipophilic compounds reaching
very high levels in the comb wax as well as being present in the
hive food stores (Mullin et al., 2010). The acaricide, coumaphos, is
a lipophilic compound applied directly into hive boxes via strips
(Milani and Iob, 1998; Rosenkranz et al., 2010); as a consequence,
it is often the compound recorded at the highest concentrations in
studies of in-hive pesticide residues in wax combs (Mullin et al.,
2010; Wu et al., 2011). This acaricide has been widely used in com-
mercial beekeeping operations in lieu of tau-fluvalinate, another
acaracide to which most Varroa populations are now resistant
(Milani, 1995; Rosenkranz et al., 2010). Coumaphos is also used
to control infestations of another parasite of bee colonies, the hive
beetle (Baxter et al., 1999).
Accumulated stress in response to disease, combined with expo-
sure to environmental toxins, could precipitate the rapid decline
of the honeybee (Hawthorne and Dively, 2011; Wu et al., 2012)
but its role in the rapid disappearance of honeybees during the
colony collapse disorder crisis remains uncertain (Johnson et al.,
2009). Chronic exposure to acaracides or other pesticides could tip
the balance in terms of whether a colony will adapt, or succumb,
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to other environmental stresses such as pathogens (Moser, 1995;
Moye and Pritsos, 2010). Like coumaphos, many pesticides are
lipophilic and accumulate in the comb wax in hives after bees come
into contact with these substances on plants while foraging (Mullin
et al., 2010; Wu et al., 2011). Two important classes of pesticide
are the organophosphates (e.g., chlorpyrifos) and the carbamates
(e.g., aldicarb) that, in common with coumaphos, are inhibitors
of an important enzyme involved in neurotransmission, acetyl-
cholinesterase (AChE), that hydrolyses acetylcholine (ACh) at the
synaptic cleft (Pohanka, 2011). The inhibition of AChE leads to
an excess of the Ach that results in prolonged activation of cholin-
ergic receptors, followed by their desensitization (Fukuto, 1990;
Pohanka, 2011).
The aim of this study was to investigate the physiological and
behavioral adaptations of adult worker honeybees to prolonged,
sub-lethal exposure to AChE inhibitors. Honeybees have two active
forms of the AChE enzyme (Belzunces et al., 1988; Badiou et al.,
2007); one form, AChEm1, is expressed at a much higher level in
the bee’s head than the other (AChEm2; Belzunces et al., 1988).
It is possible that chronic exposure to an AChE inhibitor could
affect expression of these two enzymes. For this reason, we inves-
tigated whether exposure to AChE inhibitors caused alterations in
AChE gene transcription in the honeybee brain and gut. To iden-
tify the influence of AChE inhibitors on motor function, we used
an assay for locomotion (Maze et al., 2006) to quantify how AChE
inhibitors affected locomotion, grooming, and the righting reflex.
MATERIALS AND METHODS
HONEYBEES
Honeybee colonies (Apis mellifera mellifera) were obtained from
stock of the National Bee Unit (FERA, York, UK). During the
months of January to March 2012, bees were maintained in an
indoor flight room at a temperature of 28˚C, with a 12-h light/dark
cycle. They were introduced to the flight room in early January, and
the experiments executed from January to March 2012. During the
months of May to July 2012, bees were kept outdoors and allowed
to forage freely. The experimental procedure described below was
carried out twice: the experiments were first performed on bees
taken from the indoor winter colony, then repeated using bees
taken from the outdoor summer colonies. Adult worker bees were
collected in small plastic vials from outside the colony entrance.
The vials were placed on ice until the bees were immobile, and
the bees were transferred to small plastic boxes for exposure to
pesticides as described below.
AChE INHIBITORS
Coumaphos, chlorpyrifos, aldicarb, and donepezil were obtained
as dry powders of >99% purity from Sigma-Aldrich. The com-
pounds were dissolved in DMSO to produce stock solutions of
1 mM concentration. These stock solutions were then diluted to
the working concentration to 10 nM in 1 M sucrose solution for the
first set of experiments. A second experiment exploring the influ-
ence of concentration of coumaphos on behavior was performed
using the following doses: 1µM, 100 nM, and 10 nM. Preliminary
experiments were performed to ensure that the drug concentra-
tions chosen were sub-lethal and were readily consumed by bees.
There was no difference in the survival rates (Kruskal–Wallis,
χ26 = 6.894, P = 0.331) or food consumption (Kruskal–Wallis,
χ26 = 4.13, P = 0.659) between treatment groups. Overall, mean
consumption was 143 mg syrup per bee per 24 h. The LC50 for
coumaphos was estimated in a previous study to be 751 ppm,
though this method used topical application rather than oral
dosing (Garrido et al., 2012). In our study, the coumaphos con-
centrations used equate to 363, 36.3, and 3.6 ppb; it has previously
been reported that stored food in coumaphos treated hives has a
mean coumaphos concentration of 180 ppb (Mullin et al., 2010),
making the doses chosen here field relevant for oral consump-
tion. Each honeybee from the different treatment groups therefore
consumed approximately these drug doses: 0.56 ng of donepezil,
0.25 ng of aldicarb, 0.46 ng of chlorpyrifos, and 0.47, 4.7, or 47 ng
of coumaphos.
EXPOSURE TO AChE INHIBITORS
Acetylcholinesterase inhibitors such as coumaphos are adminis-
tered directly in the colony and are soluble in wax and in food
products within the colony (Mullin et al., 2010; Wu et al., 2011;
Gomez-Perez et al., 2012). Feeding was chosen as the method of
pesticide administration to reflect the concentrations encountered
in stored food (Mullin et al., 2010); we have previously reported
that coumaphos has effects on learning and memory after oral
administration of low concentrations (Williamson et al., 2012).
After capture from outside the colony, cohorts of 10–20 hon-
eybees were placed in plastic boxes (16.5 cm× 11 cm× 6.5 cm)
which had ventilation holes in the lid, and four holes in the sides
to allow insertion of feeding tubes. The box lid had an additional
hole of 2 cm diameter to allow capture of individuals for behav-
ioral experiments; this remained covered with tape during the
treatment period. Feeding tubes were made from 2 ml microfuge
tubes with four ∼2 mm holes drilled along one side to allow the
bees to insert their mouthparts into the feeding solution. The bees
were allowed to feed ad libitum on treatment solutions in each box
for 24 h. Control bees were fed 1 M sucrose; treatment groups were
fed 1 M sucrose containing the appropriate concentration of AChE
inhibitor (see information about concentrations above). Feeding
tubes were weighed before and after the treatment regime to deter-
mine food consumption and therefore drug dose. Mortality at the
end of the 24 h treatment was also recorded.
BEHAVIORAL OBSERVATIONS
Behavioral observations were recorded using a method modified
from Maze et al. (2006). Individual bees were captured from each
treatment box without anesthetization by placing a small plastic
vial over the hole in the box lid and allowing the bee to crawl
upwards into it. The captured bee was then transferred to a plas-
tic Petri dish of 1.5 cm depth and 9 cm diameter, and allowed
to acclimatize for 5–10 min. Behavior was recorded using the
Noldus Observer software. Observation time was 15 min for each
individual, and the frequency, mean duration, and percentage of
the interval were recorded for each type of behavior. Behaviors
which had been seen in pilot observations on coumaphos treated
bees were recorded during the experiment. These behaviors were
classified as walking, flying, remaining still, falling upside down,
grooming the head, grooming the body, and unusual abdominal
spasms and movements (which included rotating, dragging, and
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tucking the abdomen, and abdominal pulsations which preceded
fecal expulsion).
AChE ASSAY
Honeybee brain and gut tissue were dissected and homogenized
in PBS and protein concentrations determined by the Bradford
assay; AChE activity was assayed at 14µg/ml using the Ell-
man’s assay. AChE inhibitors (at appropriate concentration) were
incubated for 30 min in the presence of color indicator 5′,5′-
dithiobis-2-nitrobenzoic acid (286µM), acetylthiocholine iodide
substrate (0.86 mM); AChE activity was measured via spectropho-
tometer for absorbance at 412 nm. AChE activity was normal-
ized to control measurements. IC50 values were obtained from
Hill equation fits of the data from at least three independent
replicates.
PCR AMPLIFICATION OF AChE TRANSCRIPTS
Semi-quantitative PCR was used to investigate whether AChE
inhibitor treatment altered AChE gene transcript levels in the
brain and gut of the honeybee. After AChE treatment (as described
above) bees were cold anesthetized prior to dissection. Brain tissue
and gut tissue were dissected, and the RNA extracted using Trizol®
(Invitrogen) reagent. Sample size for each extraction was brain
tissue from five animals, or gut tissue from three animals, as these
were the same tissue volume. Samples were collected three sepa-
rate times for each treatment group. Extracted RNA was subject to
treatment with DNase (Promega) to remove genomic contamina-
tion, then re-purified by phenol-chloroform extraction. Reverse
transcription was carried out using Superscript II® (Invitrogen),
and random primers. PCR was performed using a Bio-Rad T100™
thermal cycler. The reaction conditions were as follows: an initial
denaturation step at 95˚C for 3 min, followed by 35 cycles of 95˚C
for 30 s, 55˚C for 30 s, then 72˚C for 30 s, with a final extension step
of 72˚C for 5 min.
PCR was performed using GoTaq® Green Mastermix, and the
following primers: β-tubulin control (accession no. XM_394471)
forward primer, CAACGTGTACTACAACGAGG, reverse primer,
5′ TGGGTGACGGTACCACGGAG 3′; AChE-1 (accession number
XM_393751), forward primer TATCTGCGAGTTCCCGTTCG,
reverse primer GCTCCCTGCTCACCTTTA; AChE-2 (accession
number NM_001040230), forward primer ACCCGAACACCAA-
CATATCC, reverse primer CTGATCCCAAAGACCCATGT. To
ensure that equal amounts of cDNA were present in each reaction,
a mastermix was prepared containing 6µl cDNA and sufficient
reagents to perform 3µl× 50µl PCR reactions; this was mixed
well and then 48µl of the reaction mixture was transferred to
three separate tubes for addition of the gene specific primers. PCR
products were separated by agarose gel electrophoresis (2%), and
visualized by GelRed® (Biotium) staining. 12µl of PCR product
was loaded into each well. Gel images were obtained, and the rel-
ative brightness of DNA bands quantified, using the Bio-Rad Gel
Doc™ EZ imager and Image Lab™ software (version 4.0). The rel-
ative quantification was performed within-sample: from each set
of three reactions for each separate sample, β-tubulin was selected
as the reference gene, and the relative brightness therefore assigned
the value of 1. The brightness of the AChE-1 and AChE-2 bands
from the same sample were then quantified relative to this.
STATISTICAL ANALYSIS
All analyses were performed using IBM SPSS software. To identify
correlations in the behaviors for the time budgets (percentage of
the interval spent performing behaviors) and to reduce the dimen-
sionality of the data, we used a principal components method of
factor analysis (Johnson and Wichern, 1992). The resulting fac-
tor scores generated for the factors with eigenvalues greater than
0.95 were then entered into a multivariate general linear model
(MGLM). Multiple comparisons were calculated as least square
differences (LSD). Bout frequency was analyzed using Poisson
regression. Data for gene expression was analyzed using a non-
parametric median test for independent samples with post hoc
comparisons.
RESULTS
AChE INHIBITORS DISRUPT MOTOR FUNCTION AND CAUSE
ABDOMINAL SPASMS
A factor analysis was performed to identify correlations in the
behaviors measured prior to further analyses: factor analysis pro-
duced four factors that accounted for 82.8% of the variation in
the data (Table 1). The first factor, which accounted for 27.8% of
the variation in behavior, was mainly representative of the inverse
relationship between walking behavior, and upside down behav-
ior and abdominal spasms. The second factor represented the time
spent grooming,as it revealed a strong positive correlation between
head grooming and body grooming. The third and fourth factors
represented still and flying behaviors respectively and did not have
strong correlations with other behaviors.
The factor scores generated by the factor analysis were used to
test how exposure to the AChE inhibitors affected the expression
of behavior. The time of year that the bees had been used was also
included in the analysis. As represented by factor 1, bees exposed
AChE inhibitors spent slightly less time walking, and had difficulty
righting themselves when they fell over (upside down; Figure 1).
They also exhibited abdominal spasms, a behavior never observed
in the control group. Furthermore, the expression of these behav-
iors depended on the time of year the bees were assayed (MGLM
Table 1 | Factor analysis produced from whole behavioral dataset.
Factor
1 2 3 4
% Variance 27.8% 21.3% 19.2% 14.4%
Walk −0.857 −0.163 −0.458 0.007
Head grooming −0.008 0.817 0.277 −0.003
Body grooming 0.069 0.880 −0.132 −0.081
Still 0.157 0.064 0.936 −0.105
Fly −0.101 −0.069 −0.093 0.987
Upside down 0.882 −0.108 −0.292 −0.113
Abdomen spasms 0.630 0.063 0.267 −0.058
Shading indicates which behavioral variables made the largest contribution to
each factor. Factors with eigenvalues greater than 0.95 were extracted from the
data; all other factors explained 10% or less of the variation in the data, and so
were not included. N=120.
www.frontiersin.org February 2013 | Volume 4 | Article 13 | 3
Williamson et al. AChE inhibitors and honeybee physiology
FIGURE 1 |Time budget data for all behaviors from bees treated with
AChE inhibitors. Graphs show the mean percentage of the observation
interval (±SEM) spent engaged in different types of behavior. (A)Walking, (B)
upside down, (C) abdominal spasms, (D) grooming (includes both head and
body grooming), (E) still, and (F) flying. Data is pooled from both indoor
winter and outdoor summer bee colonies. N ≥23 individual bees for each
treatment group. Suc, sucrose; Coum, coumaphos; Chlor, chlorpyrifos; Ald,
aldicarb; Don, donepezil.
two-way interaction, F4,119= 2.61, P = 0.039). These data were
therefore split according to whether the bees had been taken
from the indoor winter colony or the outdoor summer colony
for further analyses (Figure 2).
For the winter bees, the behaviors represented by the first fac-
tor were not affected by AChE treatment (GLM, F4,59= 0.951,
P = 0.442), but the bees collected in the summer were (GLM,
F4,59= 2.61, P = 0.045). In summer, the chlorpyrifos treated bees
engaged in less walking behavior and spent more time upside down
and performing abdominal spasms and movements, relative to the
control bees (LSD, P = 0.007). A similar trend was observed in
the coumaphos and aldicarb treatment groups, but this was not
significant.
Factor 2 mainly represented grooming behavior, and it
was strongly influenced by AChE inhibitor exposure (MGLM,
F4,119= 2.79, P = 0.030), but this effect did not vary according to
the time of year at which the experiment was performed (MGLM,
F4,119= 0.882, P = 0.477). Factor 3, the behavior of remaining
still, and factor 4, flying behavior, were both unaffected by AChE
inhibitor treatment (MGLM, factor 3, F4,119= 0.543, P = 0.704;
factor 4, F4,119= 0.973, P = 0.425).
AChE INHIBITORS INCREASE GROOMING BEHAVIOR
Because the AChE inhibitors had a strong effect on groom-
ing behavior, we examined head and body grooming separately
(Figure 3). AChE treatment increased the total time spent groom-
ing the head (MGLM, F4,119= 4.10, P = 0.004) but not the
body (MGLM, F4,119= 1.27,P = 2.84). Aldicarb (LSD,P > 0.001)
and coumaphos (LSD, P = 0.004) were the compounds which
caused significant increases in the percentage of time spent head
grooming. The number of head grooming bouts was also affected
by AChE treatment (Pois reg., χ24 = 250, P = 0.001). All the
drug treatment groups groomed more frequently than the con-
trol (P > 0.001 for all treatments). The number of body grooming
bouts was also greater for AChE inhibitors (χ24 = 60.9, P = 0.001),
and again all treatments had an effect (aldicarb, P > 0.001; chlor-
pyrifos, P > 0.001; donepezil, P = 0.015; coumaphos, P > 0.001).
The mean duration of each grooming bout was unaffected
by AChE inhibitor (MGLM, head grooming, F4,119= 0.514,
P = 0.726; body grooming, F4,119= 1.11, P = 0.353).
COUMAPHOS HAS DOSE-DEPENDENT AND SEASONAL EFFECTS ON
GROOMING AND ABDOMINAL MOVEMENTS
The dose of the AChE inhibitors experienced during prolonged
exposure also influenced behavior. We tested the effects of three
concentrations of coumaphos on the same behaviors measured
in the previous experiment. As before, we used factor analysis
to reduce the dimensionality of the data. In this case, the factor
analysis produced three factors which accounted for 71.5% of the
variation in behavior (Table 2). The factor 1, accounting for 28.3%
of the variation, consisted of a positive correlation between both
head and body grooming behavior and abdominal spasms. Factor
2 represented an inverse relationship between walking behavior
and upside down behavior; and factor 3 represented an inverse
relationship between flying behavior and remaining still.
As before, we used the factor scores to examine the influ-
ence of the AChE inhibitor on behavior. The time of year of
the assay was also included in the analysis. Factor 1 (grooming
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FIGURE 2 |Time budget data for behaviors which were differentially
affected byAChE inhibitors according to the time of year. Graphs show
mean percentage of the observation interval (±SEM) spent engaged in the
behaviors comprising factor 1, which were affected by AChE inhibitors in
the summer, but not in the winter. (A)Walking, winter bees. (B) Upside
down, winter bees. (C) Abdominal spasms, winter bees. (D)Walking,
summer bees. (E) Upside down, summer bees. (F) Abdominal spasms,
summer bees. N ≥11 for each treatment group at each time of year. Suc,
sucrose; Coum, coumaphos; Chlor, chlorpyrifos; Ald, aldicarb; Don,
donepezil.
and abdominal spasms) was affected by both coumaphos con-
centration and the time of year (MGLM, two-way interac-
tion, F3,87= 4.56, P < 0.001). The data for these behaviors
was therefore separated according to when it was collected,
and reanalyzed (Figure 4). In winter, coumaphos treatment
affected the expression of these behaviors (GLM, F3,40= 8.53,
P < 0.001), with the 1µM treatment group performing more of
these behaviors than the controls. In summer, however, there
was no effect of coumaphos concentration on these behav-
iors (GLM, F3,46= 0.771, P = 0.516). Time budget data for
the behaviors comprising this factor are shown for both win-
ter and summer bees in Figure 4. The factors representing
all the other behaviors were unaffected by coumaphos treat-
ment (factor 2, F3,87= 1.219, P = 0.308; factor 3, F3,87= 0.492,
P = 0.689).
AChE INHIBITION IN THE BRAIN AND GUT
Biochemical assays were performed to assess the ability of the
AChE inhibitors and their activated metabolites to inhibit AChE
extracted from honeybee brain and gut tissue. Graphs show-
ing percentage AChE activity after incubation with a range of
inhibitor concentrations are shown in Figure 5. Chlorpyrifos oxon
and coumaphos oxon, and aldicarb sulfoxide (the active metabo-
lites of each AChE inhibitor) showed far greater AChE inhibition
than the parent compounds; this result was expected, because
organophosphates and carbamates are metabolically activated
in vivo to produce these more potent compounds (Dauterman,
1971; Fukuto, 1990). IC50 values for the active compounds are
shown in Table 3.
Chlorpyrifos oxon was clearly the most potent inhibitor of
AChE, and was equally potent on both tissues. For the other AChE
inhibitors, there was a difference in IC50 depending on which tis-
sue was assayed; the IC50 values were lower for the gut tissue than
for the brain, meaning that the AChE inhibition effect was greater
in the gut tissue (two-tailed t -test; coumaphos oxon and aldicarb
sulfoxide, P > 0.01; donepezil, P > 0.001).
AChE GENE TRANSCRIPTION INCREASES IN THE BRAIN AND THE GUT
IN RESPONSE TO AChE INHIBITORS
Relative transcript abundance of AChE-1 (accession number
XM_393751) and AChE-2 (accession number NM_001040230)
was measured in the brain and gut tissue from bees used in the
behavioral experiments. Graphs showing median relative expres-
sion data are shown in Figure 6. Transcript levels of AChE-1 in
the brain, but not the gut, were affected by AChE inhibitor treat-
ment (median test, brain, χ24 = 10.0, P = 0.040; gut, χ24 = 4.29,
P = 0.369). Chlorpyrifos was the only AChE inhibitor to affect
AChE-1 expression in the brain (post hoc, P = 0.05). Exposure
to AChE inhibitors had a stronger influence on expression lev-
els of AChE-2 transcripts in both brain and gut tissue (median
test, brain, χ24 = 14.0, P = 0.007; gut, χ24 = 9.64, P = 0.047).
In brain tissue, AChE-2 transcript levels increased in response
www.frontiersin.org February 2013 | Volume 4 | Article 13 | 5
Williamson et al. AChE inhibitors and honeybee physiology
FIGURE 3 |Time budget, frequency and duration data for grooming
behavior. Head and body grooming are shown separately, and data pooled
from both winter and summer. (A–C), Head grooming, (D–F) body
grooming. (A,D) Show time budget data, expressed as the mean
percentage of the observation interval (±SEM) spent engaged in each type
of grooming. (B,E) Show count data, expressed as the mean number of
times (±SEM) bees performed the grooming behavior. (C,F) Show the
mean duration (±SEM) in seconds of each grooming episode. N ≥23 for
each treatment group. Suc, sucrose; Coum, coumaphos; Chlor, chlorpyrifos;
Ald, aldicarb; Don, donepezil.
to coumaphos and aldicarb (post hoc, P = 0.05), but levels in
donepezil and chlorpyrifos treated bees were not significantly dif-
ferent to the controls (post hoc, P = 1.00, P = 0.157). (It should
be noted that AChE-2 levels were much more variable in the
chlorpyrifos treated bees than in the other treatment groups).
In gut tissue, AChE-2 levels increased in response to treatment
with coumaphos (post hoc, P = 0.015), chlorpyrifos (post hoc,
P = 0.032), and aldicarb (post hoc,P = 0.032), but not by donepezil
(post hoc, P = 0.715).
DISCUSSION
Exposure to sub-lethal doses of AChE inhibiting pesticides altered
honeybee behavior, increasing the amount and frequency of
grooming behavior, and impairing the ability to perform the
righting reflex. Abdominal spasms were also seen, particularly in
bees fed high doses of coumaphos. Exposure to AChE inhibitors
increased expression of the AChE-2 gene in both the brain and
the gut. Whether the bees were sampled from the outdoor sum-
mer colony, or the indoor winter colony, also had an effect on the
expression of the behaviors associated with the AChE inhibitors.
As observed in our experiments, exposure to AChE inhibitors
causes acute disruptions of motor function in other animals,
including rats, fish, and flies (Miller and Kennedy, 1972; Moser,
1995; Patil and David, 2010). Organophosphate and carbamate
exposure causes tremors and unusual gait in rats, and uncoor-
dinated movement and bouts of paralysis in flies (Miller and
Table 2 | Factor analysis produced from whole behavioral dataset.
Factor
1 2 3
% Variance 28.3% 52.5% 71.5%
Walk −0.460 −0.827 0.276
Head grooming 0.743 0.137 0.282
Body grooming 0.793 −0.063 −0.037
Still 0.181 0.459 −0.710
Fly 0.122 0.276 0.758
Upside down −0.055 0.797 0.210
Abdomen spasms 0.735 0.254 −0.223
Shading indicates which behavioral variables made the largest contribution to
each factor. Factors with eigenvalues greater than 1 were extracted from the
data. N=88.
Kennedy, 1972; Moser, 1995). Fish treated with organophosphates
are reported to exhibit bouts of hyperactive, erratic movement,
along with a tendency to sink to the bottom of their tank (Patil
and David, 2010). As observed in these animals, we also found that
motor function was altered by AChE inhibitors: bees walked less,
were more likely to have difficulty righting after falling over, and
exhibited strange abdominal movement and spasms. Although we
did not measure it, the effect of AChE inhibitors on motor function
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FIGURE 4 |Time budget data for bees treated with different doses of
coumaphos. Mean percentage of the observation interval (±SEM) spent
engaged in the behaviors comprising the behavioral component which was
differentially affected by the drugs according to the time of year. (A) Head
grooming, winter (B) body grooming, winter. (C) Abdominal spasms, winter.
(D) Head grooming, summer. (E) Body grooming, summer. (F) Abdominal
spasms, summer. N ≥10 For each treatment group and time of year. Cont,
control; sucrose.
could also be reflected in a disruption in flight and foraging behav-
ior. In fact, this effect could be especially profound for foragers, as
they exhibit lower levels of AChE in the brain (Shapira et al., 2001)
and so could be more likely to be affected by long-term AChE
inhibition. Acute exposure to AChE inhibitors improves learning
and memory by enhancing cholinergic transmission in honeybees
(Shapira et al., 2001; Guez et al., 2010; Williamson et al., 2012). The
effects of chronic exposure to AChE inhibitors on higher cognitive
function in bees have not yet been studied but will be impor-
tant for assessing the impact of these substances on foraging and
navigation.
Bees exposed to AChE inhibitors also spent more time groom-
ing. This is especially important because of the widespread and
deliberate application of coumaphos in honeybee colonies to com-
bat Varroa mites. The increase in grooming behavior caused by
AChE inhibitors could improve the efficacy of coumaphos as a mite
treatment (Milani and Iob, 1998) but at a cost, as exposure also
produces abdominal spasms. The abdominal spasms were often
also accompanied by both the expulsion of fecal material, and
regurgitation of crop contents, suggesting that gut function was
significantly disrupted. The effect of AChE inhibitors, especially
coumaphos, on the honeybee gut may explain why bees reared in
combs containing high levels of acaricides often also have heavy
infestations with the gut parasiteNosema ceranae (Wu et al., 2012).
It has previously been reported that food assimilation and defeca-
tion in the freshwater prawn Macrobrachium malcomsonii is also
disrupted by a carbamate pesticide (carbaryl), which may sug-
gest a common cholinergic mechanism regulating arthropod gut
functions (Bhavan et al., 2011).
The AChE activity assays demonstrated that metabolites of
coumaphos, chlorpyrifos, and aldicarb all inhibit AChE in both
brain and gut tissue from honeybees. Although it is of course dif-
ficult to correlate environmental levels of the parent compound
with levels of the active metabolite in the tissues of live bees, it is
perhaps reasonable to predict that recorded levels of organophos-
phates and carbamates in comb wax and stored pollen could cause
AChE inhibition in bees inhabiting a contaminated hive (Mullin
et al., 2010; Wu et al., 2011). The AChE inhibiting effects of the
organophosphates are of particular concern, given the high levels
of coumaphos exposure which can accumulate where it is used as
a mite treatment (Mullin et al., 2010), and given the potent AChE
inhibiting activity of chlorpyrifos oxon at even very low concentra-
tions. An interesting finding was that the AChE inhibiting activity
of donepezil and of the coumaphos and aldicarb metabolites was
more potent on extracts from gut tissue than brain tissue. Direct
inhibition of AChE in the gut provides an explanation for the
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FIGURE 5 |The effect of AChE inhibitors on honeybee AChE activity.
Inhibition of AChE activity in honeybee head and gut lysates by (A)
donepezil (DON), (B) aldicarb (ALDI) and aldicarb sulfoxide (ALDI-SO), (C)
coumaphos (COUM), coumaphos oxon (COUM-OX), and (D) chlorpyrifos
(CP) and chlorpyrifos oxon (CP-OX). AChE activity was normalized to control
measurements. Hill equation fits of the data were made using GraphPad
Prism. N =3 treatment replicates; three technical replicates were
performed for each sample.
Table 3 | IC50 values for AChE inhibitors.
Brain Gut
Coumaphos oxon 109.10±17.10 43.05±7.87
Chlorpyrifos oxon 5.23±2.30 5.11±0.33
Aldicarb sulfoxide 1101.48±166.51 439.45±66.01
Donepezil 151.19±4.47 115.03±5.86
IC50 valueswere calculated using GraphPad Prism from the dose-response curves
shown in Figure 5. Mean IC50 values are expressed in nanomolar concentrations;
SEMs are shown in brackets. N=3 biological replicates for each compound; three
technical replicates were performed for each sample.
abdominal spasms and disrupted gut function we observed in the
behavioral experiments. The differences between AChE inhibitor
potency in the gut and brain tissue extracts are more difficult to
explain, and it is unclear what physiological relevance this finding
may have. It may suggest that levels of the different AChE enzymes
differ between tissues; previous studies have identifies at least two
different AChE proteins in the honeybee (Belzunces et al., 1988;
Badiou et al., 2007).
Unfortunately, we were unable to measure transcript levels
by RT-PCR, and so cannot be absolutely certain of the level of
change expression, but our results strongly suggest that long-term
exposure to AChE inhibitors results in upregulation of transcrip-
tion of both AChEs in bees. This change did not depend on
whether the AChE inhibitor was an organophosphate or a car-
bamate compound. Interestingly, donepezil consistently affected
behavior, and AChE gene transcription, to a lesser extent than the
other compounds, despite the IC50 values from the AChE activity
assay described above indicating that it readily inhibits bee AChE
activity. This could be explained by the fact that the inhibition of
AChE by donepezil is readily reversible, over a time scale of min-
utes; whereas, the effects of aldicarb are reported to be reversible
only over several hours (Baron, 1994; Seltzer, 2005). Furthermore,
coumaphos and chlorpyrifos, irreversibly bind AChE, requiring
the synthesis of new enzyme before the effects are ameliorated
(Fukuto, 1990; Pohanka, 2011). In addition, the AChE inhibitors
had different ways of binding to the enzyme: organophosphate
and carbamate pesticides act at the active site of the enzyme, but
donepezil binds at a peripheral anion site (Fukuto, 1990; Pohanka,
2011).
Animals may adapt to pesticide exposure by short-term physi-
ological adaptations for detoxification and compensation, and by
longer-term population-level adaptations such as genetic changes
which confer reduced sensitivity (Ramphul et al., 2009; Bass and
Field, 2011; Boncristiani et al., 2012). AChE transcript levels have
been observed to change in vertebrate species after exposure to
organophosphate compounds: in the fishPanasianodonhypopthal-
mus, AChE transcript levels in the liver decreased after trichlorfon
exposure, whereas in rats, AChE transcript levels in the brain
increased after exposure to sarin (Damodaran et al., 2003; Sinha
et al., 2010). Our experiments show that AChE transcript levels
also change in the honeybee in response to organophosphate and
carbamate exposure, suggesting that this may be used as a potential
biomarker for exposure to these classes of pesticide.
Over longer timescales, increased AChE levels as a heritable
trait rather than a transient response are a common mechanism of
resistance to organophosphate pesticides (Kwon et al., 2010; Shang
et al., 2012). Organophosphate resistant spider mites Tetrany-
chus urticae have several duplications of an AChE encoding gene
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FIGURE 6 | Relative levels of twoAChE encoding transcripts in
AChE inhibitor treated bees. A box-and-whisker plot of the median
levels of AChE transcripts is shown. Levels are expressed relative to
expression of beta-tubulin control transcript in the same tissue
sample. N =3 treatment replicates, with guts from three individuals
or brains from five individuals collected from eat treatment group. (A)
AChE-1 transcript in brain tissue (B) AChE-2 transcript in brain tissue
(C) AChE-1 transcript in gut tissue (D) AChE-2 transcript in gut tissue.
Suc, sucrose; Coum, coumaphos; Chlor, chlorpyrifos; Ald, aldicarb;
Don, donepezil.
(Kwon et al., 2010). This also occurs in insects, where duplication
of the AChE-2 gene is associated with organophosphate resis-
tance in the aphid Aphis gossypii (Shang et al., 2012). Another
resistant strain of the same aphid species also shows decreased
expression of AChE-1, and increased expression of AChE-2 (Pan
et al., 2010). This is interesting in the context of AChE-1 being
the main AChE transcript in the nervous system, and the known
target of organophosphate pesticides, in the beetle Tribolium cas-
taneum; whereas the function of AChE-2 is less clear (Lu et al.,
2012). In the context of these previous studies, and the data we
present here, suggests that the increased expression of AChE-
2 may be an adaptive mechanism by which insects counteract
the inhibition of AChE-1 by organophosphate and carbamate
pesticides.
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